ReviewImmunoTargets and therapy2021

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?

Francesco Passiglia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.